Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer

Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer

ObjectivesImmune-checkpoint inhibitors (ICIs) combined with chemotherapy are more widely used than monotherapy and have shown better survival in patients with advanced non-small cell lung cancer (NSCLC) without oncogenic driver alterations. The monocyte-to-lymphocyte ratio (MLR) might predict the tr...

Full description

Bibliographic Details
Main Authors: Liang Zheng, Anning Xiong, Shuyuan Wang, Jianlin Xu, Yinchen Shen, Runbo Zhong, Jun Lu, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, Baohui Han, Hua Zhong, Wei Nie, Xueyan Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
non-small cell lung cancer (NSCLC)
prognostic value
immune checkpoint inhibitors (ICI)
chemotherapy
monocyte-to-lymphocyte ratio (MLR)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1094378/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1094378/full

Similar Items